$2.62
▼ -3.7% Today
as of Oct 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Medicus Pharma Outlines Clinical Development Strategy Across Three Drug Programs Following $90 Million in Financing
Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
MDCX earnings at a glance
Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±5.6% on average; after the most recent report on May 14, 2026 it moved +5.3%. MDCX beat the consensus EPS estimate in 0 of its last 4 reported quarters. The share price of $2.62 sits near its 52-week low.
Overview
52-week range
$2.55
$139
0% of range
Avg surprise (last 4)
-59.0%
Avg reaction (last 2)
+5.6%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.21 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-0.31 | $-0.18 | -72.2% | +26.2% | +5.3% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-0.65 | $-0.38 | -71.0% | — | — | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.43 | $-0.39 | -10.3% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.42 | $-0.23 | -82.6% | — | +5.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.24 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.44 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.21 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-11M | $-9M | — | $-15 | $-6M | $-5M | — | $-2M |
| Net income | $-12M | $-9M | — | $-21M | $-6M | $-5M | — | $-2M |
| EPS (diluted) | $-0.21 | $-0.31 | — | $-1.12 | $-0.43 | $-0.42 | — | $-0.24 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $6M | $9M | $9M | $10M | $4M | $4M | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $17M | $7M | $10M | $10M | $11M | $5M | $5M | — |
| Total assets | $27M | $7M | $10M | $10M | $12M | $6M | $6M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $29M | $6M | $10M | $11M | $9M | $4M | $3M | — |
| Total equity | $-2M | $1M | $-67,554 | $-910,126 | $3M | $2M | $3M | $5M |
Implied volatility — last 90 days
No IV snapshots yet for MDCX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
MDCX earnings FAQ
How does MDCX stock usually react to earnings?
Across the last 2 reports the average next-day move was ±5.6%, up 2 times and down 0 times.